Pharmarise Holdings Corporation (2796.T)

JPY 563.0

(-2.26%)

Annual Balance Sheets

(In JPY)
Breakdown 2024 2023 2022 2021 2020 2019
Total Assets 29.54 Billion 23.42 Billion 23.74 Billion 24.72 Billion 25.2 Billion 24.21 Billion
Total Current Assets 13.73 Billion 11.37 Billion 10.87 Billion 10.54 Billion 10.67 Billion 9.6 Billion
Cash And Short Term Investments 7.15 Billion 4.74 Billion 3.99 Billion 4.6 Billion 4.47 Billion 4.4 Billion
Cash and Cash Equivalents 7.1 Billion 4.74 Billion 3.99 Billion 4.6 Billion 4.47 Billion 4.4 Billion
Short Term Investments 50 Million -1.92 Billion -2.07 Billion -2.42 Billion -2.02 Billion -2.12 Billion
Net Receivables 3.55 Billion 605 Million 479 Million 926 Million 957 Million 780 Million
Inventory 2.64 Billion 2.29 Billion 2.3 Billion 2.58 Billion 2.64 Billion 2.11 Billion
Other Current Assets 386 Million 317 Million 315 Million 260 Million 227 Million 229 Million
Total Non-Current Assets 15.8 Billion 12.04 Billion 12.86 Billion 14.17 Billion 14.52 Billion 14.61 Billion
Net PPE 6.19 Billion 6 Billion 6.35 Billion 6.43 Billion 6.33 Billion 6.29 Billion
Good Will And Intangible Assets 6.41 Billion 3.24 Billion 3.62 Billion 4.46 Billion 5.28 Billion 5.17 Billion
Good Will 5.91 Billion 2.74 Billion 3.22 Billion 4.02 Billion 4.69 Billion 4.87 Billion
Intangible Assets 500 Million 501 Million 408 Million 438 Million 587 Million 301 Million
Long-Term Investments 234 Million 2 Billion 2.13 Billion 2.48 Billion 2.09 Billion 2.56 Billion
Tax Assets 891 Million 778 Million 741 Million 786 Million 802 Million 549 Million
Other Non Current Assets 2.06 Billion - - 4 Million 13 Million 34 Million
Other Assets - 7 Million 5 Million 5 Million 5 Million 2 Million
Total Liabilities 22.09 Billion 16.43 Billion 17.04 Billion 18.39 Billion 19.26 Billion 18.6 Billion
Total Current Liabilities 10.68 Billion 9.83 Billion 8.47 Billion 9.39 Billion 10.03 Billion 9.34 Billion
Account Payables 5.69 Billion 4.25 Billion 4.1 Billion 4.6 Billion 5.19 Billion 5.02 Billion
Tax Payables 286 Million 333 Million 429 Million 573 Million 324 Million 171 Million
Short Term Debt 2.83 Billion 3.67 Billion 2.49 Billion 2.81 Billion 3.09 Billion 2.94 Billion
Deferred Revenue 123 Million 1.15 Billion 1.18 Billion 1.31 Billion 928 Million 830 Million
Other Current Liabilities 2.04 Billion 747 Million 691 Million 645 Million 820 Million 551 Million
Total Non Current Liabilities 11.41 Billion 6.6 Billion 8.57 Billion 9 Billion 9.22 Billion 9.25 Billion
Long-Term Debt 9.65 Billion 5.46 Billion 7.42 Billion 7.87 Billion 8.13 Billion 8.19 Billion
Deferred Revenue Non Current 5 Million -42 Million -31 Million - - 705 Million
Deferred Tax Liabilities Non Current - - - - - -
Other Non Current Liabilities 1.69 Billion 1.13 Billion 1.14 Billion 1.12 Billion 1.09 Billion 354 Million
Other Liabilities - - - - - -
Total Equity 7.44 Billion 6.98 Billion 6.69 Billion 6.33 Billion 5.94 Billion 5.61 Billion
Stock Holders Equity 7.36 Billion 6.88 Billion 6.6 Billion 6.22 Billion 5.9 Billion 5.46 Billion
Common Stock 1.96 Billion 1.29 Billion 1.27 Billion 1.25 Billion 1.22 Billion 1.22 Billion
Retained Earnings 3.53 Billion 4.01 Billion 3.81 Billion 3.49 Billion 3.19 Billion 2.74 Billion
Accumulated other comprehensive income 242 Million 226 Million 203 Million 208 Million 214 Million 176 Million
Common Stock Equity 7.36 Billion 6.88 Billion 6.6 Billion 6.22 Billion 5.9 Billion 5.46 Billion
Capital Lease Obligation 264 Million 432 Million 551 Million 700 Million 854 Million 620 Million
Total Investments 284 Million 82 Million 60 Million 61 Million 68 Million 444 Million
Total Debt 12.74 Billion 9.13 Billion 9.91 Billion 10.69 Billion 11.22 Billion 11.13 Billion
Net Debt 5.64 Billion 4.39 Billion 5.92 Billion 6.09 Billion 6.75 Billion 6.73 Billion

Balance Sheet Charts